Newsbenzinga
Moderna Burns Cash, Suffers Fresh Vaccine Setback
· Published
Article summary
Moderna (MRNA) Q2 Earnings: Beat estimates with $145M in sales and a $1.97 EPS loss. Reaffirms 2026 sales guidance.
An excerpt from the original article.Moderna (MRNA) Q2 Earnings: Beat estimates with $145M in sales and a $1.97 EPS loss. Reaffirms 2026 sales guidance.
An excerpt from the original article.
Comments —
Loading comments…